ELIZABETH KELLAM: Open Payments
NPI 1518381482 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 27 payments from 9 companies in 2025. Trend: 2023 $736 · 2024 $955 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $363 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Dexcom, Inc. | 3 | $59 |
| SANOFI-AVENTIS U.S. LLC | 2 | $56 |
| Novo Nordisk Inc | 3 | $46 |
| CeQur Corporation | 1 | $30 |
| Sequel Med Tech, LLC | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Globus Medical, Inc. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, RECORLEV, Dexcom G6 Transmitter, TZIELD, Ozempic, CeQur Simplicity, TWIIST, TEPEZZA.
Industry payments across SC — which companies pay providers there.
